Cryo-Cell International (CCEL) Short Interest Ratio & Short Volume

Short interest is the volume of Cryo-Cell International shares that have been sold short but have not yet been covered or closed out. As of November 14th, investors have sold 5,598 shares of CCEL short. 0.11% of Cryo-Cell International's shares are currently sold short. Learn More on Cryo-Cell International's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CCEL shares currently have a short interest ratio of 1.3. Learn More on Cryo-Cell International's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.11% of Cryo-Cell International's floating shares are currently sold short.

Cryo-Cell International saw a decline in short interest in November. As of November 14th, there was short interest totaling 5,598 shares, a decline of 45.9% from the previous total of 10,342 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.11% of Cryo-Cell International's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Cryo-Cell International: Biodesix, Inc. (2.46%), Sera Prognostics, Inc. (1.03%), DocGo Inc. (6.74%), Exagen Inc. (3.47%), EUDA Health Holdings Limited (0.19%), P3 Health Partners Inc. (1.26%), Concord Medical Services Holdings Limited (0.18%), Pacific Health Care Organization Inc. (0.01%), Basel Medical Group Ltd (0.59%), American Shared Hospital Services (0.04%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($79.41 billion), Invesco QQQ ($31.14 billion), iShares Russell 2000 ETF ($20.32 billion), iShares 20+ Year Treasury Bond ETF ($12.61 billion), AppLovin Corporation ($9.14 billion), Palo Alto Networks, Inc. ($8.94 billion), SPDR S&P Biotech ETF ($8.68 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($6.85 billion), Robinhood Markets, Inc. ($5.59 billion), and Strategy Inc ($5.49 billion). View all of the most shorted stocks.

Short selling CCEL is an investing strategy that aims to generate trading profit from Cryo-Cell International as its price is falling. CCEL shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cryo-Cell International occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CCEL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CCEL, twice per month. The most recent reporting period available is November, 14 2025.